Veerhealth Care Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Small Cap

Veerhealth Care announced that the company has executed & delivered export order valued at US$ 50,000 (approximately Rs 41.50 lakhs), another export order valued at $ 197,793 (approximately Rs 1.65 crore) which shall be fully executed and delivered by end of July.

Now Company has received an additional export order worth $ 106,673 (approximately Rs 89 lakhs), also company is expecting monthly repeat orders from the same Top US Institutional Supplier. In addition to this, Company is renovating its existing plant in Vapi, Gujarat to set up a bigger plant which will be US FDA & WHO compliant.

In February 2024, Company announced its ambitious expansion plans with a proposed investment of Rs 33 crore. This investment encompasses various aspects including the acquisition of land near to its existing plant, construction of buildings, procurement of plant and machinery, and development of essential infrastructure.

Powered by Capital Market - Live News

Net loss of Veerhealth Care reported to Rs 0.55 crore in the quarter ended March 2024 as against net profit of Rs 1.04 crore during the previous quarter ended March 2023. Sales declined 9.65% to Rs 3.37 crore in the quarter ended March 2024 as against Rs 3.73 crore during the previous quarter ended March 2023.

For the full year,net profit declined 74.05% to Rs 0.41 crore in the year ended March 2024 as against Rs 1.58 crore during the previous year ended March 2023. Sales declined 0.38% to Rs 13.22 crore in the year ended March 2024 as against Rs 13.27 crore during the previous year ended March 2023.

Powered by Capital Market - Live News

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 30 May 2024

Powered by Capital Market - Live News

Veerhealth Care has received an export order worth US$ 197793 (Rs 1.65 crore approx.) from one of the top institutional supplier company in the United States of America.

Powered by Capital Market - Live News